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Introduction
Nickel is one of the most frequent contact allergens. It is a constituent of various different alloys and, hence, occurs in numerous metal items used in life, from which it can be released in varying amounts in the presence of bodily fluids, including sweat and saliva (1) . Nickel ions can generate neoantigens, or signal 1, needed for the activation of nickelspecific T cells. Whether the obligatory co-stimulation (signal 2) required for T cell priming is provided by an adjuvant effect of nickel ions themselves or by a variety of different cofactors subsumed under the term 'danger' (2) remains an unresolved issue. The latter possibility is supported by the clinical experience that nickel allergy preferentially develops after nickel has been in contact with an inflamed or irritated skin, whereas sensitization is unlikely to occur with the intact skin. Consistent with this, the majority of humans fails to become sensitized to nickel despite its ubiquitous occurrence (3), and interestingly, they possess nickel-specific CD4 + CD25 + T regulatory (Treg) cells (4) . In fact, even though a reduction in dermal nickel exposure has been shown to decrease the incidence of newly sensitized nickel allergics (3), other epidemiological observations suggest that nickel hypersensitivity is lowered in the presence of elevated environmental levels of this potential sensitizer (5) .
In both humans and experimental animals, most of the bodily absorption of nickel is through oral consumption (6), a route known to obviate the induction of contact hypersensitivity (CHS) for some other allergens and to favor the induction of Treg cells and tolerance (7) . Consistent with this, an increased oral nickel uptake rendered experimental animals unresponsive to the induction of nickel allergy (8) (9) (10) . Moreover, there is solid epidemiological evidence to indicate that in at least some wearers of dental braces, nickel tolerance may be acquired due to the continuous release of low amounts of nickel from such braces (11) . Interestingly, however, the amount of nickel released from the braces is negligible when compared with the total daily uptake from food (;0. 3 ) (1, 12, 13) . This paradox raises questions about the potential effects of different exposure conditions and the dose-response relationship of oral nickel tolerance and nickel-specific Treg cells, respectively. Treg cells specific for nickel have been described as CD4 + CD25 + in non-allergic humans (4) . In mice exposed to a high concentration of oral nickel, both CD4 
Methods

Reagents
NiCl 2 Á6H 2 O (denoted as NiCl 2 ) and 2,4-dinitrofluorobenzene (DNFB) were purchased from Sigma-Aldrich Chemie GmbH (Steinheim, Germany), and H 2 O 2 was obtained from E. Merck (Darmstadt, Germany).
Antibodies
Allophycocyanin (APC)-labeled streptavidin and the following anti-mouse antibodies were purchased from BD PharMingen (Heidelberg, Germany): APC-anti-CD3e (145-2C11), PerCP-anti-CD4 (RM4-5), PE-and biotin-anti-CD8b.2 (53-5.8), purified anti-CD16/CD32 (2.4G2), FITC-anti-CD25 (7D4), PE-anti-CD25 (PC61), PE-anti-a IEL chain (M290), PEanti-I-A/I-E (M5/114.15.2) and FITC-anti-TCRb chain (H57-597). Anti-CD25 mAb was harvested from hybridoma PC61 (14) . The magnetically labeled anti-mouse MHC-II, antimouse CD4 and anti-PE microbeads were obtained from Miltenyi Biotec GmbH (Bergisch Gladbach, Germany).
Mice
Ni low mice were specific pathogen-free C57BL/6J mice obtained from Janvier (Le Genest St Isle, France). They were bred and reared in a conventional environment with cage covers and water bottle tips made from nickel-containing stainless steel (grade 304; DIN no. 14301); they received tap water without additional nickel supplementation. Ni very low mice were generated by breeding and rearing Ni low mice for two generations in a nickel-reduced environment using cage covers and water bottle lids made of plastic and glass, respectively. Ni high mice were generated by giving Ni low mice 10 mM NiCl 2 in the drinking water for 4-6 weeks.
All mice received a standard rodent diet (Sniff Spezialdiaeten, Soest, Germany) and were kept in accordance with the animal husbandry, as described in previous papers (8, 15) . They were 7-10 weeks old at the onset of experiments. All investigations were carried out using female mice.
Determination of nickel concentration
Nickel concentration in urine, feces and organs of individual animals were determined by atomic absorption spectroscopy using a Zeeman 4100 ZL spectrometer (PerkinElmer, Boston, MA, USA). In the case of Ni high mice, the excretions and bodily organs were obtained 1 day after cessation of a 4-week period of oral nickel administration, and age-matched Ni low and Ni very low mice were used as controls. The animals (three to five mice per group) were bled by heart puncture, and the organs and feces were handled with teflon-coated instruments to avoid contamination by nickel ions released from stainless steel instruments. To further reduce contamination by nickel ions, plastic pipettes and sample collection tubes were washed with 10% NH 4 Cl, rinsed with the same aqua bidest as that used for atomic absorption spectroscopy and dried in a heating oven overnight. Samples were prepared for the analysis by high-pressure ashing.
Sensitization of mice
Mice were primed as described previously (8) 
Challenge for recall and ear-swelling test
Ten days after priming, mice were challenged for recall by injecting 50 ll of 10 mM NiCl 2 in sterile, pyrogen-free saline into the pinna of each ear or by applying 50 ll of 0.2% DNFB onto each ear. Forty-eight hours after challenge with NiCl 2 and 24 h after challenge with DNFB, delayed-type hypersensitivity (DTH) reactions were determined by measuring the increment in ear thickness compared with prechallenge values. For determination of pre-challenge values, mice were anesthetized; for measurement post-challenge, they were sacrificed by asphyxiation with CO 2 . Measurements were performed in a blind fashion using a micrometer (Oditest D 1000 gauge, The Dyer Co., Lancaster, PA, USA). The data shown represent individual experiments comprising groups of five to six mice each, the mean ear-swelling response is expressed in units of mm 3 10 À2 + SEM.
Adoptive T cell transfer
In all transfer experiments, Ni very low mice (five to six animals per group) were used as recipients. Suspensions of the indicated type and number cell were injected intravenously (i.v.) into recipient mice (150 ll per mouse). To study the ability of transferred T cells in preventing subsequent sensitization to nickel, recipients were primed i.d. 1 day after adoptive transfer; 10 days after priming, they were challenged for recall at the ears, and 48 h after recall, their ear-swelling response was measured. This experimental approach was used for all experiments except that shown in Fig. 4B in which the capacity of transferred T cells to suppress the elicitation of hypersensitivity in nickel-sensitized mice was studied. Here, recipients were primed 10 days prior to transfer; 1 day after transfer, they were challenged at the ears and 48 h later ear-swelling responses were determined.
Cell enrichment and sorting
To enrich donor T cells, single-cell suspensions of erythrocyte-free splenocytes were prepared in complete RPMI medium (PAA Laboratories, Coelbe, Germany) containing 10% FCS and passed through nylon wool columns. Eluted T cells were then further purified by either depletion of MHC-II + cells to obtain total T cells or depletion of MHC-II + cells followed by positive selection of CD4 + or CD8 + T cells using MACS microbeads labeled with the respective mAbs (Miltenyi Biotec GmbH). The sorted T cells were contaminated with <1% MHC-II + cells; the sorted CD4 + and CD8 + T cells contained <1% CD8
+ and <2% CD4 + T cells, respectively. In some experiments, the sorted CD8 + and CD4 + T cells were recombined in a 1:1 ratio prior to injection into the recipients.
To obtain CD4 + a E b 7 À T cells, sorted CD4 + T cells were incubated with PE-labeled mAb against a E integrin (CD103), followed by anti-PE microbeads. After depletion of a E b 7 + T cells, the remaining contamination by such cells in the CD4
+
CD25
+ T cell subset was ;4%.
Flow cytometry
For phenotyping T cells, single-cell suspensions were prepared in PBS and pre-incubated with anti-CD16/CD32 mAb (Fc block), before staining with the respective antibodies. For the determination of total CD4 + CD25 + T cells (Fig. 8A ) and the population of a E b 7 + T cells among CD4 + CD25 + T cells (Fig. 8B ), 15 and 13 mice were individually analyzed. Flow cytometry was performed using a FACSCalibur (BD Biosciences, Heidelberg, Germany), and the results were analyzed with CellQuest software.
In vivo depletion of CD25 + cells
Hybridoma PC61 was grown to over-confluent levels in DMEM medium (PAA Laboratories) supplemented with 10% ultra-low IgG FCS (PAN Biotech GmbH, Aidenbach, Germany). Anti-CD25 mAb was then obtained using a Hitrap Protein G column with an Ä KTA prime (Amersham Pharmacia Biotech, Uppsala, Sweden). After concentrating the antibody molecules using centripreps (Millipore GmbH, Eschborn, Germany), the concentration levels were determined by standard protein assays. Purified anti-CD25 mAb (0.25 mg per mouse) was injected intra-peritoneally (i.p.) into either Ni high or Ni low mice, and 3 days later the mice were sacrificed and their spleen cells isolated, as described above.
Statistical analysis
Statistical significance of results was determined by analysis of variance (ANOVA) followed by Newman-Keuls test. Oneway ANOVA tests were performed using GraphPad Prism (GraphPad software, San Diego, CA, USA). (8, 16, 17) . Here, we asked whether or not there is a corresponding difference between Ni low and Ni very low mice. To increase skin inflammation and irritation, we used intradermal rather than epicutaneous application to induce hypersensitivity to nickel (15 (Fig. 2, bar 6 ). In either case, the immune response of Ni very low mice was nickel specific, because these nickelprimed mice failed to elicit an ear-swelling response when recalled with DNFB ( Fig. 2 , bars 9 and 10). Moreover, DNFB-immunized mice showed high ear-swelling responses when recalled with DNFB ( Fig. 2 (Fig. 3A, bar 3) . The suppression exerted by the transferred Ni low T cells was nickel specific (Fig. 3A, bar 7 versus 9) ; the specificity of Treg cells from Ni high mice has been demonstrated elsewhere (8) .
Results
Analysis of nickel concentration in tissues and
Knowing that Treg cells from Ni high and Ni low mice can completely or partially prevent the post-transfer sensitization toward nickel, respectively (Fig. 3A) , we asked whether they were also able to inhibit the elicitation of nickel hypersensitivity in already sensitized mice. Therefore, T cells from Ni high , Ni low or Ni very low donors were transferred into Ni very low recipients that were sensitized 10 days before transfer (Fig. 3B) . In contrast to non-suppressive Ni very low T cells, Ni high T cells profoundly suppressed the elicitation of nickel hypersensitivity and this was irrespective of how hypersensitivity was induced (Fig. 3B, bars 4 (Fig. 4A, bar 4) , as many as 10 6 Ni low T cells were required to achieve the same effect (Fig. 4C,  bar 7) . Clearly, the number and/or type of nickel-specific Treg cells generated within Ni high mice are superior to those from Ni low mice. (8) (Fig. 5A, bar 8) . We have now used the same experimental approach in order to compare the effects of CD4
+ and CD8 + T cell sub-populations obtained from Ni low donors. As anticipated (cf. Fig. 3 ), T cell subsets from Ni very low donors, or combinations thereof, were unable to prevent the sensitization at any of the cell numbers transferred (Fig.  5A-C) . In contrast to CD8 + T cells, CD4 + T cells from Ni high (10 3 ) and Ni low (10 6 ) donors were able to prevent post-transfer sensitization by NiCl 2 alone (bar 4 in Fig. 5B and C, respectively). In contrast, when the recipients were immunized with NiCl 2 /H 2 O 2 , a transfer of even 10 4 Ni high CD4 + T cells still failed to prevent their sensitization (Fig. 5A, bar 4) . In fact, CD8
+ T cells from these donors were devoid of any suppressive capacity when transferred alone (bar 6 in Fig.  5A-C (Fig. 5A, bar 8 ). This conclusion is drawn from the results obtained from the transfer of the individual T cell subsets (10 4 ) which were unable to prevent hypersensitivity (Fig. 5A, bars 4 and 8) .
Taken together, the data shown in Fig. 5 demonstrate that nickel tolerance, as induced by adoptive cell transfer into Ni very low recipients, is a fine blend between the mode of recipient immunization (NiCl 2 alone or with H 2 O 2 ), the amount of oral nickel exposure of the T cell donor and the transferred T cell subsets (CD8 + and/or CD4 + ). (Fig. 6D) ; the Ni very low recipients were immunized after transfer with either NiCl 2 /H 2 O 2 (Fig. 6C) or NiCl 2 alone (Fig. 6B, D and E) . Indeed, the cell types and numbers specified sufficed to transfer nickel tolerance when the donor mice had not been depleted of CD25
+ cells prior to transfer (bar 3 of Fig. 6B-E) . However, when the CD4 + T cells from either Ni high or Ni low donors were depleted of CD25 + cells, their capacity to prevent the sensitization by NiCl 2 alone was alleviated (bar 2 in Fig. 6B and D) Fig. 5A and B) , but required the co-transfer of Ni high CD4 + T cells (Fig. 5A, bar 8) . Therefore, it is conceivable that the maintenance of suppressor activity by unsorted CD25 À Ni high T cells (bar 2 in Fig. 6C and E) + cells from these CD4 + T cells were depleted, however, the suppression partially disappeared (Fig. 7, bars 3 
and 5).
Together with the results shown in Fig. 6 Fig. 8 (left panel) , an increased oral uptake of nickel (cf. Fig. 1 Since Ni low mice received the same food and drinking water as Ni very low mice, the only additional nickel ions accessible to the former were those released from their stainless steel cage covers (by saliva and gnawing) and drinking bottle lids (through water contact and licking). This elevated oral nickel uptake of Ni low mice was verified by their small but significantly higher nickel concentration in the spleen and feces. This background level of nickel is enough to induce a state of partial tolerance which protects Ni low mice from being sensitized by nickel ions alone, albeit not by nickel ions combined with the adjuvant H 2 O 2 (or other adjuvants) (15; Fig. 2) . A similar scenario exists in humans: continuous exposure to nickel in the oral cavity (from orthodontic braces) was found to correlate with a decreased incidence of nickel allergy (20) . A possible explanation for this partial nickel tolerance of Ni low mice and wearers of , Ni low and Ni high mice. Results represent one of two experiments yielding very similar results. In this and the following figures, asterisks denote a significant statistical difference (*P < 0.05, **P < 0.01 and ***P < 0.001).
orthodontic braces could be that, as in hamsters (21) (Fig. 3A, bar 3 and Fig. B,  bar 5 ). In contrast, Ni low Treg cells that were unable to suppress the subsequent immunization with NiCl 2 /H 2 O 2 (Fig. 3A , bar 6) were also unable to inhibit a secondary response after sensitization with NiCl 2 /H 2 O 2 (Fig. 3B, bar 7) . Collectively, these data support the notion that nickel-specific regulatory T cells are not only able to suppress the immunization within a time frame of 10 days but also secondary immune responses within 2 days upon adoptive transfer.
The suppressive capacity of CD4 + CD25 + Treg cells has been widely established (18 + a E b 7 À T cells (19, 24) , and in vivo a E b 7 expression is important for CD4 + CD25 + Treg cells to enter into the inflamed tissue and suppress activated T cells (25) . In our experimental system, CD4 + CD25 + a E b 7 + T cells were more effective than CD4 + CD25 + a E b 7 À T cells in preventing nickel hypersensitivity in Ni very low mice. Additional studies are needed to clarify whether the enhanced suppressive capacity of CD4 + CD25
+ a E b 7 + T cells is due to a superior suppressive ability on a single-cell level, a better homing potential or a combination of the two. Consistent with published data (19, 24) , those CD4 + CD25 + T cells that fail to express a E b 7 probably also show some degree of suppressive capacity because we observed that removal of a E b 7 + T cells from CD4 + T cells only partially alleviated the suppression.
It is well established that oral administration of antigens favors tolerance induction, include CD4 + CD25 + Treg cell differentiation (26) . These CD4 +
CD25
+ Treg cells rapidly divided preferentially in gut lymphoid tissue (27) . Multiple (28), and short after oral antigen uptake, expression of these cytokines up-regulated (29 (20) . Since none of the animals was primed and the only difference between the three mouse subsets was their exposure to nickel, one can indirectly conceive that an increasing nickel concentration in the body is associated with an increase in the variety of different neoantigens induced by nickel ions and, consequently, different nickel-reactive T cell clones and Treg cells. In correlation with this, the percentage of CD25
+ cells among CD4 + T cells and the percentage of a E b 7 + cells among CD4 + CD25 + T cells were both significantly higher in Ni high mice when compared with Ni low mice (Fig. 8) . Therefore, a higher exposure to nickel may lead to a more diverse nickel-reactive T cell repertoire and thus account for the differences in the strengths of the differentiated Treg cell populations (including the CD8 + T cells in Ni high mice) in preventing hypersensitivity responses. 
Interestingly, nickel-specific CD8
+ Treg cells could be identified in Ni high mice. A possible explanation for this could be that only in the Ni high mice the self-proteins bound to nickel reach a high enough concentration so that sufficient numbers of nickel-induced neoantigens are presented to CD8 + T cells (33, 34) . In order to be cross-presented by MHC-I molecules, extracellular antigens have to be presented at a high concentration (34) (35) (36) + suppressor-effector T cells has been observed in other models (37) (38) (39) (40) (41) (42) , but the mode of interaction of these cells remains poorly understood. As an example, when tolerance to trinitrophenol (TNP) was induced by i.v. injection of TNPcoupled syngeneic splenocytes, the tolerance transfer by CD8 + T suppressor-effector cells required either the cotransfer of TNP-specific CD4 + T suppressor-inducers or treatment of recipient mice with agonistic anti-CD40 mAb (43) . These findings suggest that the CD8 + T suppressor-effector cells acquire some kind of help from activated CD4 + T suppressor-inducers which act through their CD40 ligand. With regard to the daily amount of nickel per kilogram body weight that is taken up from food and drinking water (12) , there appears to be no fundamental difference between humans and Ni low mice, and conceivably, the same is true for the nickel-specific CD4 + CD25 + Treg cells described in non-allergic humans (4) and the Ni low mice studied here. In these animals, the protection provided by CD4 + CD25 + Treg cells could account for the lack of sensitization when humans encounter nickel ions on the intact skin, that is, in the absence of danger. However, when human exposure to nickel occurs in the context of danger, such as ear piercing or irritated skin, CD4
+ CD25 + Treg cells may be less sufficient at protecting from sensitization. Furthermore, we hypothesize that if the oral uptake of nickel in humans were as low as that of our Ni very low mice, humans might lack nickel-specific Treg cells altogether; thus, an increase in the incidence of nickel allergy would ensue.
By definition, the hypersensitivity induced in our study is a DTH rather than CHS reaction. Although CHS is one type of DTH response, it differs from other forms of DTH responses. While the effector T cells in DTH response are CD4 T cells, those in CHS response are mainly CD8 T cells, although in some instance can also be CD4 T cells. Furthermore, in DTH responses, CD4 T cells act as effector T cells whereas they exert a regulatory function in CHS responses (46, 47) . In this respect, our nickel model well fits the standard of a DTH response since Ni low mice sensitized by injection of NiCl 2 /H 2 O 2 harbor CD4 effector cells (15, X. Wu et al., unpublished data). By this standard, nickel allergy in humans is also not a pure CHS response since nickel-reactive T cells in human peripheral blood are mainly of the CD4 + subtype (48) (49) (50) . Actually, when we further study the cause of nickel allergy in human, one can find that nickel allergy is really not pure CHS response because it can be caused by either contact nickel at irritated skin or 'intradermal' contact such as ear piercing, the latter is typical DTH response. Therefore, our mouse model is a useful animal model to study nickel allergy and tolerance with relevance to human nickel allergy.
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